Royal DSM (stand 7B10), a global science-based company active in nutrition, health and sustainable living, invites you to discover the evolving role of vitamins and lipids in pharmaceutical applications at CPhI Worldwide 2018
Emerging scientific research continually highlights the beneficial impact of therapeutic, high-dose vitamin intake on widespread, chronic diseases such as diabetes mellitus, cardiovascular disease (CVD) and chronic low back pain.
As the premier global supplier for vitamins, carotenoids and lipid active pharmaceutical ingredients (APIs), DSM is uniquely positioned to help both brand and generic manufacturers realise market success.
DSM invites visitors to learn more about innovation opportunities with vitamins as APIs. DSM’s innovation pipeline is focused on addressing the latest research on the novel therapeutic effects of vitamins, as well as the development of vitamin combinations with established APIs.
Although combinations such as NSAIDs with B vitamins and contraceptives with folate are commercially available in several countries, DSM continues to take the lead in bringing novel vitamin combinations to market for indications such as chronic low back pain, osteoarthritis, hypertension, type 2 diabetes, IBD and ulcer treatment, with the goal of improving quality of life and adding value for patients and healthcare professionals alike.
DSM is the first and only company in the world that can provide access to both US Drug Master Files (DMFs) and Certificates of Suitability (CEPs) for all 13 vitamins, providing its pharmaceutical partners a competitive advantage by accelerating the registration and market entry process, enabling timelier patient access.
DSM’s 400-strong R&D team and global network of regulatory specialists provide the foundation for a full suite of end-to-end service offerings.
DSM prides itself on having proven success in quality assurance and ensuring a reliable supply of products to customers worldwide.
The company draws on its unique skills in chemical synthesis and biotechnology to ensure all products meet strict sustainability standards. DSM’s commitment to making substantial future investments in excellence and sustainability also means global production network remains cutting edge and high quality.
Book a meeting with DSM at CPhI, where a number of production and innovation concepts will be highlighted and demonstrated, ultimately designed to accelerate and optimise the product commercialisation process.
Join in on the festivities at the DSM booth from 16:00–18:00 on October 9 and 10 as DSM celebrates 60 years of Vitamin C production at its Scotland plant.
Based in Dalry, it is the only remaining western-based vitamin production site and is dedicated to sustainable, traceable and high-quality manufacturing. Drinks and hors d’oeuvres will be served.